Surescripts is up for sale and has hired a bank to search for potential buyers, including private equity firms. The company dominates electronic prescribing, processing 2.5 billion prescriptions in 2023. Surescripts, the healthcare technology company that facilitates most electronic prescribing in the US, is exploring a sale, Business Insider has learned. The privately-held company hired healthcare investment bank TripleTree and is looking for potential buyers, including private equity firms, according to two people with knowledge of the deal. Surescripts, formed by a merger in 2008, has long dominated e-prescribing, providing the connectivity that allows doctors to send prescriptions from their electronic health records to pharmacies.

---

Persons: Surescripts Organizations: CVS Health, Business